Amendment to Funding Agreement between Edison ICAV (Essex Fund) and Kodiak Sciences Inc. and Subsidiary
This agreement, dated July 22, 2021, is between Edison ICAV (acting for the Essex Fund) as the buyer, and Kodiak Sciences Inc. and its subsidiary Kodiak Sciences GmbH as the sellers. It amends a previous Funding Agreement from December 1, 2019, by confirming that the second payment will not be made and setting the total purchase price at $100 million. All other terms of the original Funding Agreement remain unchanged.
Exhibit 10.1
THIS AGREEMENT, dated July 22, 2021 is made and entered into by and between Edison ICAV, an Irish Collective Investment Asset-management Vehicle, acting for and on behalf of its sub-fund, the Essex Fund, as assignee of Baker Bros. Advisors, LP, a Delaware limited partnership (the “Buyer”), and Kodiak Sciences Inc., a Delaware corporation (“Kodiak”) together with its Subsidiary Kodiak Sciences GmbH, a Swiss corporation (“Kodiak GmbH”, and with Kodiak, the “Sellers”) and relates to a Funding Agreement dated December 1, 2019 (the “Funding Agreement”). All capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them in the Funding Agreement.
Sellers and Buyer agree as follows:
Signed on July 22, 2021.
SELLERS
Kodiak Sciences Inc. |
| Kodiak Sciences GmbH |
|
By: /s/ Victor Perlroth |
| By: /s/ Victor Perlroth |
|
Name/Title: Victor Perlroth, Chief Executive Officer |
| Name/Title: Victor Perlroth, Chairman |
|
BUYER
Edison ICAV, Acting for and on behalf of its Sub-Fund The Essex Fund |
|
|
By: /s/ Scott L. Lessing |
|
|
Name/Title: Scott L. Lessing, Director |
|
|